Clinical Trial

ED90 of Epidural Bupivacaine With Lidocaine for the Initiation of Labor Analgesia

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor after receiving a lidocaine "test dose"
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-09-14; most recent amendment 2026-07-10.
Status change: Not Yet Recruiting → Recruiting 2023-02-06
Trial Details
NCT Number NCT05543694
Lead Sponsor Brigham and Women's Hospital
Conditions Labor Pain, Analgesia
Enrollment 120 participants
Start Date 2022-10-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-13